Semantic search

is a:FF:0000410 (human Lymphatic Endothelial cells 0min after VEGFC treatment sample),FF:0000411 (human Lymphatic Endothelial cells 15min after VEGFC treatment sample),FF:0000412 (human Lymphatic Endothelial cells 30min after VEGFC treatment sample),FF:0000413 (human Lymphatic Endothelial cells 45min after VEGFC treatment sample),FF:0000414 (human Lymphatic Endothelial cells 1hr after VEGFC treatment sample),FF:0000415 (human Lymphatic Endothelial cells 80min after VEGFC treatment sample),FF:0000416 (human Lymphatic Endothelial cells 100min after VEGFC treatment sample),FF:0000417 (human Lymphatic Endothelial cells 2h after VEGFC treatment sample),FF:0000418 (human Lymphatic Endothelial cells 2.5h after VEGFC treatment sample),FF:0000419 (human Lymphatic Endothelial cells 3h after VEGFC treatment sample),FF:0000420 (human Lymphatic Endothelial cells 3.5h after VEGFC treatment sample),FF:0000421 (human Lymphatic Endothelial cells 4h after VEGFC treatment sample),FF:0000422 (human Lymphatic Endothelial cells 5h after VEGFC treatment sample),FF:0000423 (human Lymphatic Endothelial cells 6h after VEGFC treatment sample),FF:0000424 (human Lymphatic Endothelial cells 7h after VEGFC treatment sample),FF:0000425 (human Lymphatic Endothelial cells 8h after VEGFC treatment sample),FF:0000426 (human MCF7 breast cancer cell line 0min after EGF1 treatment sample),FF:0000427 (human MCF7 breast cancer cell line 15min after EGF1 treatment sample),FF:0000428 (human MCF7 breast cancer cell line 30min after EGF1 treatment sample),FF:0000429 (human MCF7 breast cancer cell line 45min after EGF1 treatment sample),FF:0000430 (human MCF7 breast cancer cell line 1hr after EGF1 treatment sample),FF:0000431 (human MCF7 breast cancer cell line 80min after EGF1 treatment sample),FF:0000432 (human MCF7 breast cancer cell line 100min after EGF1 treatment sample),FF:0000433 (human MCF7 breast cancer cell line 2h after EGF1 treatment sample),FF:0000434 (human MCF7 breast cancer cell line 2.5h after EGF1 treatment sample),FF:0000435 (human MCF7 breast cancer cell line 3h after EGF1 treatment sample),FF:0000436 (human MCF7 breast cancer cell line 3.5h after EGF1 treatment sample),FF:0000437 (human MCF7 breast cancer cell line 4h after EGF1 treatment sample),FF:0000438 (human MCF7 breast cancer cell line 5h after EGF1 treatment sample),FF:0000439 (human MCF7 breast cancer cell line 6h after EGF1 treatment sample),FF:0000440 (human MCF7 breast cancer cell line 7h after EGF1 treatment sample),FF:0000441 (human MCF7 breast cancer cell line 8h after EGF1 treatment sample),FF:0000442 (MCF7 breast cancer cell line 0min after HRG treatment),FF:0000443 (human MCF7 breast cancer cell line 15min after HRG treatment sample),FF:0000444 (human MCF7 breast cancer cell line 30min after HRG treatment sample),FF:0000445 (human MCF7 breast cancer cell line 45min after HRG treatment sample),FF:0000446 (human MCF7 breast cancer cell line 1hr after HRG treatment sample),FF:0000447 (human MCF7 breast cancer cell line 80min after HRG treatment sample),FF:0000448 (human MCF7 breast cancer cell line 100min after HRG treatment sample),FF:0000449 (human MCF7 breast cancer cell line 2h after HRG treatment sample),FF:0000450 (human MCF7 breast cancer cell line 2.5h after HRG treatment sample),FF:0000451 (human MCF7 breast cancer cell line 3h after HRG treatment sample),FF:0000452 (human MCF7 breast cancer cell line 3.5h after HRG treatment sample),FF:0000453 (human MCF7 breast cancer cell line 4h after HRG treatment sample),FF:0000454 (human MCF7 breast cancer cell line 5h after HRG treatment sample),FF:0000455 (human MCF7 breast cancer cell line 6h after HRG treatment sample),FF:0000456 (human MCF7 breast cancer cell line 7h after HRG treatment sample),FF:0000457 (human MCF7 breast cancer cell line 8h after HRG treatment sample),FF:0000458 (mouse ST2 Mesenchymal stem cells, cells 15 min after adipogenic induction sample),FF:0000459 (mouse ST2 Mesenchymal stem cells, cells 30 min after adipogenic induction sample),FF:0000460 (mouse ST2 Mesenchymal stem cells, cells 1hr after adipogenic induction sample),FF:0000461 (mouse ST2 Mesenchymal stem cells, cells 2hr after adipogenic induction sample),FF:0000462 (mouse ST2 Mesenchymal stem cells, cells 3hr after adipogenic induction sample),FF:0000463 (mouse ST2 Mesenchymal stem cells, cells 6hr after adipogenic induction sample),FF:0000464 (mouse ST2 Mesenchymal stem cells, cells 12hr after adipogenic induction sample),FF:0000465 (mouse ST2 Mesenchymal stem cells, cells 18hr after adipogenic induction sample),FF:0000466 (mouse ST2 Mesenchymal stem cells, cells 24hr after adipogenic induction sample),FF:0000467 (mouse ST2 Mesenchymal stem cells, cells 36hr after adipogenic induction sample),FF:0000468 (mouse ST2 Mesenchymal stem cells, cells 48hr after adipogenic induction sample),FF:0000469 (mouse ST2 Mesenchymal stem cells, cells 72hr after adipogenic induction sample),FF:0000470 (mouse ST2 Mesenchymal stem cells, cells 96hr after adipogenic induction sample),FF:0000471 (mouse ST2 Mesenchymal stem cells, cells 120hr after adipogenic induction sample),FF:0000472 (mouse ST2 Mesenchymal stem cells, cells 144hr after adipogenic induction sample),FF:0000473 (mouse ST2 Mesenchymal stem cells, cells 15 min after osteogenic induction sample),FF:0000474 (mouse ST2 Mesenchymal stem cells, cells 30 minafter osteogenic induction sample),FF:0000475 (mouse ST2 Mesenchymal stem cells, cells 1hr after osteogenic induction sample),FF:0000476 (mouse ST2 Mesenchymal stem cells, cells 2hr after osteogenic induction sample),FF:0000477 (mouse ST2 Mesenchymal stem cells, cells 3hr after osteogenic induction sample),FF:0000478 (mouse ST2 Mesenchymal stem cells, cells 6hr after osteogenic induction sample),FF:0000479 (mouse ST2 Mesenchymal stem cells, cells 12hr after osteogenic induction sample),FF:0000480 (mouse ST2 Mesenchymal stem cells, cells 18hr after osteogenic induction sample),FF:0000481 (mouse ST2 Mesenchymal stem cells, cells 24hr after osteogenic induction sample),FF:0000482 (mouse ST2 Mesenchymal stem cells, cells 36hr after osteogenic induction sample),FF:0000483 (mouse ST2 Mesenchymal stem cells, cells 48hr after osteogenic induction sample),FF:0000484 (mouse ST2 Mesenchymal stem cells, cells 72hr after osteogenic induction sample),FF:0000485 (mouse ST2 Mesenchymal stem cells, cells 96hr after osteogenic induction sample),FF:0000486 (mouse ST2 Mesenchymal stem cells, cells 120hr after osteogenic induction sample),FF:0000487 (mouse ST2 Mesenchymal stem cells, cells 144hr after osteogenic induction sample),FF:0000488 (mouse ST2 Mesenchymal stem cells, cells 0hr after medium change , without induction sample),FF:0000489 (ST2 Mesenchymal stem cells, cells 1hr after medium change , without induction),FF:0000490 (ST2 Mesenchymal stem cells, cells 6hr after medium change , without induction),FF:0000491 (ST2 Mesenchymal stem cells, cells 12hr after medium change , without induction),FF:0000492 (ST2 Mesenchymal stem cells, cells 24hr after medium change , without induction),FF:0000493 (ST2 Mesenchymal stem cells, cells 48hr after medium change , without induction),FF:0000494 (ST2 Mesenchymal stem cells, cells 72hr after medium change , without induction),FF:0000495 (ST2 Mesenchymal stem cells, cells 96hr after medium change , without induction),FF:0000496 (ST2 Mesenchymal stem cells, cells 120hr after medium change , without induction),FF:0000497 (mouse ST2 Mesenchymal stem cells, cells 144hr after medium change , without induction sample),FF:0000498 (mouse J2E erythroblastic leukemia line 0min after treatment with erythropoietin sample),FF:0000499 (mouse J2E erythroblastic leukemia line 15min after treatment with erythropoietin sample),FF:0000500 (mouse J2E erythroblastic leukemia line 30min after treatment with erythropoietin sample),FF:0000501 (mouse J2E erythroblastic leukemia line 45min after treatment with erythropoietin sample),FF:0000502 (mouse J2E erythroblastic leukemia line 1hr after treatment with erythropoietin sample),FF:0000503 (mouse J2E erythroblastic leukemia line 1hr 20min after treatment with erythropoietin sample),FF:0000504 (mouse J2E erythroblastic leukemia line 1hr 40min after treatment with erythropoietin sample),FF:0000505 (mouse J2E erythroblastic leukemia line 2hr after treatment with erythropoietin sample),FF:0000506 (mouse J2E erythroblastic leukemia line 2hr 30min after treatment with erythropoietin sample),FF:0000507 (mouse J2E erythroblastic leukemia line 3hr after treatment with erythropoietin sample),FF:0000508 (mouse J2E erythroblastic leukemia line 3hr 30min after treatment with erythropoietin sample),FF:0000509 (mouse J2E erythroblastic leukemia line 4hr after treatment with erythropoietin sample),FF:0000510 (mouse J2E erythroblastic leukemia line 6hr after treatment with erythropoietin sample),FF:0000511 (mouse J2E erythroblastic leukemia line 12hr after treatment with erythropoietin sample),FF:0000512 (mouse J2E erythroblastic leukemia line 24hr after treatment with erythropoietin sample),FF:0000513 (mouse J2E erythroblastic leukemia line 48hr after treatment with erythropoietin sample),FF:0000514 (human K562 erythroblastic leukemia line 0min after treatment with hemin sample),FF:0000515 (human K562 erythroblastic leukemia line 15min after treatment with hemin sample),FF:0000516 (human K562 erythroblastic leukemia line 30min after treatment with hemin sample),FF:0000517 (human K562 erythroblastic leukemia line 45min after treatment with hemin sample),FF:0000518 (human K562 erythroblastic leukemia line 1hr after treatment with hemin sample),FF:0000519 (human K562 erythroblastic leukemia line 1hr 20min after treatment with hemin sample),FF:0000520 (human K562 erythroblastic leukemia line 1hr 40min after treatment with hemin sample),FF:0000521 (human K562 erythroblastic leukemia line 2hr after treatment with hemin sample),FF:0000522 (human K562 erythroblastic leukemia line 2hr 30min after treatment with hemin sample),FF:0000523 (human K562 erythroblastic leukemia line 3hr after treatment with hemin sample),FF:0000524 (human K562 erythroblastic leukemia line 3hr 30min after treatment with hemin sample),FF:0000525 (human K562 erythroblastic leukemia line 4hr after treatment with hemin sample),FF:0000526 (human K562 erythroblastic leukemia line 6hr after treatment with hemin sample),FF:0000527 (human K562 erythroblastic leukemia line 12hr after treatment with hemin sample),FF:0000528 (human K562 erythroblastic leukemia line 24hr after treatment with hemin sample),FF:0000529 (human K562 erythroblastic leukemia line 48hr after treatment with hemin sample),FF:0000530 (human K562 erythroblastic leukemia line 72hr after treatment with hemin sample),FF:0000531 (human K562 erythroblastic leukemia line 96hr after treatment with hemin sample),FF:0000532 (human H9 Embryoid body cells 0 days after melanocytic induction sample),FF:0000533 (human H9 Embryoid body cells 1 day after melanocytic induction sample),FF:0000534 (human H9 Embryoid body cells 3 days after melanocytic induction sample),FF:0000535 (human H9 Embryoid body cells 6 days after melanocytic induction sample),FF:0000536 (human H9 Embryoid body cells 9 days after melanocytic induction sample),FF:0000537 (human H9 Embryoid body cells 12 days after melanocytic induction sample),FF:0000538 (human H9 Embryoid body cells 15 days after melanocytic induction sample),FF:0000539 (human H9 Embryoid body cells 18 days after melanocytic induction sample),FF:0000540 (human H9 Embryoid body cells 21 days after melanocytic induction sample),FF:0000541 (human H9 Embryoid body cells 24 days after melanocytic induction sample),FF:0000542 (human H9 Embryoid body cells 27 days after melanocytic induction sample),FF:0000544 (human H9 Embryoid body cells 34 days after melanocytic induction sample),FF:0000545 (human H9 Embryoid body cells 41 days after melanocytic induction sample),FF:0000546 (human Aortic Smooth Muscle cells 0min after treatment with FGF2 sample),FF:0000547 (human Aortic Smooth Muscle cells 15min after treatment with FGF2 sample),FF:0000548 (human Aortic Smooth Muscle cells 30min after treatment with FGF2 sample),FF:0000549 (human Aortic Smooth Muscle cells 45min after treatment with FGF2 sample),FF:0000550 (human Aortic Smooth Muscle cells 1hr after treatment with FGF2 sample),FF:0000551 (human Aortic Smooth Muscle cells 2hr after treatment with FGF2 sample),FF:0000552 (human Aortic Smooth Muscle cells 3hr after treatment with FGF2 sample),FF:0000553 (human Aortic Smooth Muscle cells 4hr after treatment with FGF2 sample),FF:0000554 (human Aortic Smooth Muscle cells 5hr after treatment with FGF2 sample),FF:0000555 (human Aortic Smooth Muscle cells 6hr after treatment with FGF2 sample),FF:0000556 (human Aortic Smooth Muscle cells 0min after treatment with IL1b sample),FF:0000557 (human Aortic Smooth Muscle cells 15min after treatment with IL1b sample),FF:0000558 (human Aortic Smooth Muscle cells 30min after treatment with IL1b sample),FF:0000559 (human Aortic Smooth Muscle cells 45min after treatment with IL1b sample),FF:0000560 (human Aortic Smooth Muscle cells 1hr after treatment with IL1b sample),FF:0000561 (human Aortic Smooth Muscle cells 2hr after treatment with IL1b sample),FF:0000562 (human Aortic Smooth Muscle cells 3hr after treatment with IL1b sample),FF:0000563 (human Aortic Smooth Muscle cells 4hr after treatment with IL1b sample),FF:0000564 (human Aortic Smooth Muscle cells 5hr after treatment with IL1b sample),FF:0000565 (human Aortic Smooth Muscle cells 6hr after treatment with IL1b sample),FF:0000566 (human Monocyte-derived macrophages 0min after LPS treatment sample),FF:0000567 (human Monocyte-derived macrophages 15min after LPS treatment sample),FF:0000568 (human Monocyte-derived macrophages 30min after LPS treatment sample),FF:0000569 (human Monocyte-derived macrophages 45min after LPS treatment sample),FF:0000570 (human Monocyte-derived macrophages 1h after LPS treatment sample),FF:0000571 (human Monocyte-derived macrophages 80min after LPS treatment sample),FF:0000572 (human Monocyte-derived macrophages 100min after LPS treatment sample),FF:0000573 (human Monocyte-derived macrophages 2h after LPS treatment sample),FF:0000574 (human Monocyte-derived macrophages 2.5h after LPS treatment sample),FF:0000575 (human Monocyte-derived macrophages 3h after LPS treatment sample),FF:0000576 (human Monocyte-derived macrophages 3.5h after LPS treatment sample),FF:0000577 (human Monocyte-derived macrophages 4h after LPS treatment sample),FF:0000578 (human Monocyte-derived macrophages 5h after LPS treatment sample),FF:0000579 (human Monocyte-derived macrophages 6h after LPS treatment sample),FF:0000580 (human Monocyte-derived macrophages 7h after LPS treatment sample),FF:0000581 (human Monocyte-derived macrophages 8h after LPS treatment sample),FF:0000582 (human Monocyte-derived macrophages 10h after LPS treatment sample),FF:0000583 (human Monocyte-derived macrophages 12h after LPS treatment sample),FF:0000584 (human Monocyte-derived macrophages 14h after LPS treatment sample),FF:0000585 (human Monocyte-derived macrophages 16h after LPS treatment sample),FF:0000586 (human Monocyte-derived macrophages 18h after LPS treatment sample),FF:0000587 (human Monocyte-derived macrophages 20h after LPS treatment sample),FF:0000588 (human Monocyte-derived macrophages 22h after LPS treatment sample),FF:0000589 (human Monocyte-derived macrophages 24h after LPS treatment sample),FF:0000590 (human Monocyte-derived macrophages 36h after LPS treatment sample),FF:0000591 (human Monocyte-derived macrophages 48h after LPS treatment sample),FF:0000592 (human H9 Embryonic Stem cells sample),FF:0000593 (human Saos2 osteosarcoma cell line 0min after induction of calcification with ascorbate and BPG sample),FF:0000594 (human Saos2 osteosarcoma cell line 15min after induction of calcification with ascorbate and BPG sample),FF:0000595 (human Saos2 osteosarcoma cell line 30min after induction of calcification with ascorbate and BPG sample),FF:0000596 (human Saos2 osteosarcoma cell line 45min after induction of calcification with ascorbate and BPG sample),FF:0000597 (human Saos2 osteosarcoma cell line 60min after induction of calcification with ascorbate and BPG sample),FF:0000598 (human Saos2 osteosarcoma cell line 80min after induction of calcification with ascorbate and BPG sample),FF:0000599 (human Saos2 osteosarcoma cell line 100min after induction of calcification with ascorbate and BPG sample),FF:0000600 (human Saos2 osteosarcoma cell line 2h after induction of calcification with ascorbate and BPG sample),FF:0000601 (human Saos2 osteosarcoma cell line 2.5h after induction of calcification with ascorbate and BPG sample),FF:0000602 (human Saos2 osteosarcoma cell line 3h after induction of calcification with ascorbate and BPG sample),FF:0000603 (human Saos2 osteosarcoma cell line 4h after induction of calcification with ascorbate and BPG sample),FF:0000604 (human Saos2 osteosarcoma cell line 8h after induction of calcification with ascorbate and BPG sample),FF:0000605 (human Saos2 osteosarcoma cell line 24h after induction of calcification with ascorbate and BPG sample),FF:0000606 (human Saos2 osteosarcoma cell line 4d after induction of calcification with ascorbate and BPG sample),FF:0000607 (human Saos2 osteosarcoma cell line 7d after induction of calcification with ascorbate and BPG sample),FF:0000608 (human Saos2 osteosarcoma cell line 14d after induction of calcification with ascorbate and BPG sample),FF:0000609 (human Saos2 osteosarcoma cell line 21d after induction of calcification with ascorbate and BPG sample),FF:0000610 (human Saos2 osteosarcoma cell line 28d after induction of calcification with ascorbate and BPG sample),FF:0000623 (mouse EBF KO HPCs induced to T cell 120h sample),FF:0000690 (human mesenchymal stem cells adipose derived, 0 minutes after adipogenic induction sample),FF:0000691 (human mesenchymal stem cells adipose derived, 15 minutes after adipogenic induction sample),FF:0000692 (human mesenchymal stem cells adipose derived, 30 minutes after adipogenic induction sample),FF:0000693 (human mesenchymal stem cells adipose derived, 45 minutes after adipogenic induction sample),FF:0000694 (human mesenchymal stem cells adipose derived, 60 minutes after adipogenic induction sample),FF:0000695 (human mesenchymal stem cells adipose derived, 80 minutes after adipogenic induction sample),FF:0000696 (human mesenchymal stem cells adipose derived, 100 minutes after adipogenic induction sample),FF:0000697 (human mesenchymal stem cells adipose derived, 120 minutes after adipogenic induction sample),FF:0000698 (human mesenchymal stem cells adipose derived, 150 minutes after adipogenic induction sample),FF:0000699 (human mesenchymal stem cells adipose derived, 180 minutes after adipogenic induction sample),FF:0000700 (human mesenchymal stem cells adipose derived, 12 hours after adipogenic induction sample),FF:0000701 (human mesenchymal stem cells adipose derived, 24 hours after adipogenic induction sample),FF:0000702 (human mesenchymal stem cells adipose derived, 2 days after adipogenic induction sample),FF:0000706 (human mesenchymal stem cells adipose derived, 14 days after adipogenic induction sample),FF:0000707 (human mesenchymal stem cells adipose derived, untreated control sample),FF:0000710 (human Saos2 osteosarcoma cell line timecourse control sample),FF:0000730 (human melanocyte (MC) sample),FF:0000731 (human adipocyte differentiation day4 sample),FF:0000732 (human adipocyte differentiation day8 sample),FF:0000733 (human adipocyte differentiation day12 sample),FF:0011101 (human CD14-positive monocytes - mock treated sample),FF:0011102 (human CD14-positive monocytes - treated with B-glucan sample),FF:0011103 (human CD14-positive monocytes - treated with BCG sample),FF:0011104 (human CD14-positive monocytes - treated with Candida sample),FF:0011105 (human CD14-positive monocytes - treated with Cryptococcus sample),FF:0011106 (human CD14-positive monocytes - treated with Group A streptococci sample),FF:0011108 (human CD14-positive monocytes - treated with lipopolysaccharide sample),FF:0011109 (human CD14-positive monocytes - treated with Salmonella sample),FF:0011113 (mouse CD326-positive enterocyte isolated from mice- treated with RANKL- day03 sample),FF:0011121 (CD4-positiveCD25-CD45RA- naive conventional T cells expanded),FF:0011127 (CD4-positiveCD25-positiveCD45RA- naive regulatory T cells expanded),FF:0011132 (human Hep-2 cells mock treated sample),FF:0011133 (human Hep-2 cells treated with Streptococci strain 5448 sample),FF:0011134 (human Hep-2 cells treated with Streptococci strain JRS4 sample),FF:0011137 (mouse natural helper cells- IL2 treated sample),FF:0011138 (mouse natural helper cells- IL33 treated- 01hr sample),FF:0011139 (mouse natural helper cells- IL33 treated- day02 sample),FF:0011194 (mouse trophoblast stem cell line R1AB differentiation- day00 sample),FF:0011196 (mouse trophoblast stem cell line R1AB differentiation- day02 sample),FF:0011197 (mouse trophoblast stem cell line R1AB differentiation- day03 sample),FF:0011198 (mouse trophoblast stem cell line R1AB differentiation- day04 sample),FF:0011199 (mouse trophoblast stem cell line R1AB differentiation- day05 sample),FF:0011200 (mouse trophoblast stem cell line R1AB differentiation- day06 sample),FF:0011201 (mouse trophoblast stem cell line Rybp differentiation- day00 sample),FF:0011202 (mouse trophoblast stem cell line Rybp differentiation- day01 sample),FF:0011203 (mouse trophoblast stem cell line Rybp differentiation- day02 sample),FF:0011204 (mouse trophoblast stem cell line Rybp differentiation- day03 sample),FF:0011205 (mouse trophoblast stem cell line Rybp differentiation- day04 sample),FF:0011206 (mouse trophoblast stem cell line Rybp differentiation- day05 sample)